Delivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model

Tissue Engineering - Part A

Volumn 17, Issue 5-6, 2011, Pages 751-763

  Chew, Sue Anne ^a   Kretlow, James D ^a   Spicer, Patrick P ^a   Edwards, Austin W ^a   Baggett, L Scott ^a   Tabata, Yasuhiko ^b   Kasper, F Kurtis ^a   Mikos, Antonios G ^a  

^a Rice University   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADABLE POLYMERS; BIOMOLECULES; BONE; COMPUTERIZED TOMOGRAPHY; CROSSLINKING; DEFECTS; ENCODING (SYMBOLS); GENE THERAPY; GENE TRANSFER; NUCLEIC ACIDS; POLYMERS; SCAFFOLDS; TISSUE ENGINEERING;

BONE FORMATION; BONE MORPHOGENETIC PROTEIN-2; COMPOSITE SCAFFOLDS; CROSS-LINKING DENSITY; DEFECT MODEL; DEGRADATION RATE; GELATIN MICROPARTICLES; GENE DELIVERY SYSTEMS; IN-VITRO; MICROCOMPUTED TOMOGRAPHY; PLASMID DNA; PLASMID DNA (PDNA); POLYCATIONIC POLYMERS; POLYPLEXES; POROUS TISSUE; POST-IMPLANTATION; RELEASE KINETICS; SLOW DEGRADATION;

DEGRADATION;

RATTUS;

BONE MORPHOGENETIC PROTEIN 2; DNA; POLYAMINE; POLYCATIONS; POLYMER; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; BIOREMEDIATION; BONE DEVELOPMENT; CELL DEATH; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; FIBROBLAST; FISCHER 344 RAT; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; KINETICS; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; PLASMID; POROSITY; RADIOGRAPHY; RAT; SKULL;

ANIMALS; BIODEGRADATION, ENVIRONMENTAL; BONE MORPHOGENETIC PROTEIN 2; CELL DEATH; DISEASE MODELS, ANIMAL; DNA; FIBROBLASTS; GENE TRANSFER TECHNIQUES; HUMANS; KINETICS; OSTEOGENESIS; PLASMIDS; POLYAMINES; POLYMERS; POROSITY; RATS; RATS, INBRED F344; SKULL; TISSUE SCAFFOLDS; TRANSFECTION; X-RAY MICROTOMOGRAPHY;

EID: 79952141729     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0496     Document Type: Article

References (38)

1. Deckers, M. M., van Bezooijen, R. L., van der Horst, G., Hoogendam, J., van der Bent, C., Papapoulos, S. E., and Lowik, C. W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor a. Endocrinology 143, 1545, 2002.
2. Akino, K., Mineta, T., Fukui, M., and Akita, S. P-ii-04 early phase regulation of human mesenchymal stem cells and the unique profile of the proliferation by bone morphogenetic protein-2. Wound Repair Regen 12, A6, 2004.
3. Akino, K., Mineta, T., Fukui, M., Fujii, T., and Akita, S. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair Regen 11, 354, 2003.
4. Reddi, A. H. Bone morphogenetic proteins, bone marrow stromal cells, and mesenchymal stem cells. Maureen Owen revisited. Clin Orthop Relat Res 313, 115, 1995.
5. Sakou, T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22, 591, 1998.
6. Hosseinkhani, H., Azzam, T., Kobayashi, H., Hiraoka, Y., Shimokawa, H., Domb, A. J., and Tabata, Y. Combination of 3d tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells. Biomaterials 27, 4269, 2006.
7. Chen, Y. Orthopedic applications of gene therapy. J Orthop Sci 6, 199, 2001.
8. Niyibizi, C., Baltzer, A., Lattermann, C., Oyama, M., Whalen, J. D., Robbins, P. D., and Evans, C. H. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop Relat Res 355 Suppl, S148, 1998.
9. Patel, Z. S., Young, S., Tabata, Y., Jansen, J. A., Wong, M. E., and Mikos, A. G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
10. Young, S., Patel, Z. S., Kretlow, J. D., Murphy, M. B., Mountziaris, P. M., Baggett, L. S., Ueda, H., Tabata, Y., Jansen, J. A., Wong, M., and Mikos, A. G. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 15, 2347, 2009.
11. Chew, S. A., Hacker, M. C., Saraf, A., Raphael, R. M., Kasper, F. K., and Mikos, A. G. Altering amine basicities in biodegradable branched polycationic polymers for non-viral gene delivery. Biomacromolecules 11, 600, 2010.
12. Patel, Z. S., Ueda, H., Yamamoto, M., Tabata, Y., and Mikos, A. G. In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 25, 2370, 2008.
13. Kasper, F. K., Young, S., Tanahashi, K., Barry, M. A., Tabata, Y., Jansen, J. A., and Mikos, A. G. Evaluation of bone regeneration by DNA release from composites of oligo (poly (ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect. J Biomed Mater Res A 78 A, 335, 2006.
14. Kasper, F. K., Kushibiki, T., Kimura, Y., Mikos, A. G., and Tabata, Y. In vivo release of plasmid DNA from composites of oligo (poly (ethylene glycol) fumarate) and cationized gelatin microspheres. J Control Release 107, 547, 2005.
15. Kasper, F. K., Jerkins, E., Tanahashi, K., Barry, M. A., Tabata, Y., and Mikos, A. G. Characterization of DNA release from composites of oligo (poly (ethylene glycol) fumarate) and cationized gelatin microspheres in vitro. J Biomed Mater Res A 78, 823, 2006.
16. Huang, Y. C., Simmons, C., Kaigler, D., Rice, K. G., and Mooney, D. J. Bone regeneration in a rat cranial defect with delivery of pei-condensed plasmid DNA encoding for bone morphogenetic protein-4 (bmp-4). Gene Ther 12, 418, 2005.
17. Patel, Z. S., Yamamoto, M., Ueda, H., Tabata, Y., and Mikos, A. G. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater 4, 1126, 2008.
18. Kasper, F. K., Tanahashi, K., Fisher, J. P., and Mikos, A. G. Synthesis of poly (propylene fumarate). Nat Protoc 4, 518, 2009.
19. Shi, X., Sitharaman, B., Pham, Q. P., Liang, F., Wu, K., Edward Billups, W., Wilson, L. J., and Mikos, A. G. Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials 28, 4078, 2007.
20. Chew, S. A., Hacker, M. C., Saraf, A., Raphael, R. M., Kasper, F. K., and Mikos, A. G. Biodegradable branched polycationic polymers with varying hydrophilic spacers for nonviral gene delivery. Biomacromolecules 10, 2436, 2009.
21. Tabata, Y., Hijikata, S., Muniruzzaman, M., and Ikada, Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10, 79, 1999.
22. Holland, T. A., Tessmar, J. K., Tabata, Y., and Mikos, A. G. Transforming growth factor-beta 1 release from oligo (poly (ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release 94, 101, 2004.
23. Kim, H. J., Kwon, M. S., Choi, J. S., Yang, S. M., Yoon, J. K., Kim, K., and Park, J. S. Highly effective and slow-biodegradable network-type cationic gene delivery polymer: small library-like approach synthesis and characterization. Biomaterials 27, 2292, 2006.
24. Loscher, W., Reissmuller, E., and Ebert, U. Anticonvulsant effect of fosphenytoin in amygdala-kindled rats: comparison with phenytoin. Epilepsy Res 30, 69, 1998.
25. Allen, F. H. J., Runge, J. W., Legarda, S., Maria, B. L., Matsuo, F., Fischer, J. H., Kugler, A. R., and Basson, S. M. Safety, tolerance and pharmacokinetics of intravenous fosphenytoin (cerebyx) in status epilepticus. Epilepsia 36, 90, 1995.
26. Pack, A. M. The association between antiepileptic drugs and bone disease. Epilepsy Curr 3, 91, 2003.
27. Amling, M., Priemel, M., Holzmann, T., Chapin, K., Rueger, J. M., Baron, R., and Demay, M. B. Rescue of the skeletal phenotype of vitamin d receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140, 4982, 1999.
28. Kloeckner, J., Bruzzano, S., Ogris, M., and Wagner, E. Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties. Bioconjug Chem 17, 1339, 2006.
29. Walter, E., Moelling, K., Pavlovic, J., and Merkle, H. P. Microencapsulation of DNA using poly (dl-lactide-coglycolide): stability issues and release characteristics. J Control Release 61, 361, 1999.
30. Wang, D., Robinson, D. R., Kwon, G. S., and Samuel, J. Encapsulation of plasmid DNA in biodegradable poly (d, l-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Control Release 57, 9, 1999.
31. Huang, Z., Nelson, E. R., Smith, R. L., and Goodman, S. B. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. Tissue Eng 13, 2311, 2007.
32. Lalani, Z., Wong, M., Brey, E. M., Mikos, A. G., and Duke, P. J. Spatial and temporal localization of transforming growth factor-beta1, bone morphogenetic protein-2, and platelet-derived growth factor-a in healing tooth extraction sockets in a rabbit model. J Oral Maxillofac Surg 61, 1061, 2003.
33. Pouton, C. W., and Seymour, L. W. Key issues in non-viral gene delivery. Adv Drug Deliv Rev 34, 3, 1998.
34. Choate, K. A., and Khavari, P. A. Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther 8, 1659, 1997.
35. Levy, M. Y., Barron, L. G., Meyer, K. B., and Szoka, F. C., Jr. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Ther 3, 201, 1996.
36. Park, J. S., and Lakes, R. S. Biomaterials: An Introduction. New York: Plenum Press, 1992.
37. Shea, L. D., Smiley, E., Bonadio, J., and Mooney, D. J. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17, 551, 1999.
38. Termaat, M. F., Den Boer, F. C., Bakker, F. C., Patka, P., and Haarman, H. J. Bone morphogenetic proteins. Development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 87, 1367, 2005.